High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.
暂无分享,去创建一个
S. Hatakeyama | H. Yotsuyanagi | K. Moriya | A. Hisaka | K. Okamoto | Takehito Yamamoto | Y. Nukui | Nahoko Yata | H. Suzuki
[1] F. Pea,et al. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. , 2012, The Journal of antimicrobial chemotherapy.
[2] Kana Matsumoto,et al. Correlation between serum linezolid concentration and the development of thrombocytopenia , 2012, Scandinavian journal of infectious diseases.
[3] Kana Matsumoto,et al. Influence of Linezolid Clearance on the Induction of Thrombocytopenia and Reduction of Hemoglobin , 2011, The American journal of the medical sciences.
[4] S. Higuchi,et al. Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese Patients , 2011, Antimicrobial Agents and Chemotherapy.
[5] N. Yamanaka,et al. Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[6] Tsutomu Kobayashi,et al. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[7] H. Ikeuchi,et al. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[8] Y. Yazdanpanah,et al. Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia? , 2010, The Journal of antimicrobial chemotherapy.
[9] P. Viale,et al. Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis , 2010, Antimicrobial Agents and Chemotherapy.
[10] Kazuaki Matsumoto,et al. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction. , 2010, International journal of antimicrobial agents.
[11] Elizabeth M. Wells,et al. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid , 2010, Current medical research and opinion.
[12] M. Metersky,et al. A comparison of linezolid with glycopeptides in severe MRSA pneumonia , 2009, Expert review of anti-infective therapy.
[13] M. Yasuda,et al. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy. , 2009, Clinical therapeutics.
[14] D. Vinh,et al. Linezolid: a review of safety and tolerability. , 2009, The Journal of infection.
[15] Kaori Ito,et al. Population Pharmacokinetic Analysis of Linezolid in Patients With Infectious Disease: Application to Lower Body Weight and Elderly Patients , 2009, Journal of clinical pharmacology.
[16] John L. Johnson,et al. Population Pharmacokinetics of Linezolid in Adults with Pulmonary Tuberculosis , 2009, Antimicrobial Agents and Chemotherapy.
[17] V. Anttila,et al. Appearance of ring sideroblasts in bone marrow during linezolid therapy , 2009, Scandinavian journal of infectious diseases.
[18] Kazuaki Matsumoto,et al. Renal function as a predictor of linezolid-induced thrombocytopenia. , 2009, International journal of antimicrobial agents.
[19] William J. Peppard,et al. Pharmacologic options for CNS infections caused by resistant Gram-positive organisms , 2008, Expert review of anti-infective therapy.
[20] C. Hamilton,et al. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series. , 2007, Diagnostic microbiology and infectious disease.
[21] C. Kloft,et al. Does Linezolid Inhibit Its Own Metabolism?—Population Pharmacokinetics As a Tool to Explain the Observed Nonlinearity in Both Healthy Volunteers and Septic Patients , 2007, Drug Metabolism and Disposition.
[22] Á. Soriano,et al. Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections , 2007, European Journal of Clinical Microbiology & Infectious Diseases.
[23] Yen-Hung Lin,et al. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. , 2006, International journal of antimicrobial agents.
[24] B. Howden,et al. Good Clinical Outcomes but High Rates of Adverse Reactions during Linezolid Therapy for Serious Infections: a Proposed Protocol for Monitoring Therapy in Complex Patients , 2006, Antimicrobial Agents and Chemotherapy.
[25] A. Angeloni,et al. Environmental factors influence the rate of human herpesvirus type 8 infection in a population with high incidence of classic Kaposi sarcoma. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] K. Wu,et al. Multistate Outbreak of Listeriosis Linked to Turkey Deli Meat and Subsequent Changes in US Regulatory Policy , 2006 .
[27] K. Wu,et al. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] M. Singer,et al. Pharmacokinetic studies of linezolid and teicoplanin in the critically ill. , 2005, The Journal of antimicrobial chemotherapy.
[29] Y. Yazdanpanah,et al. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. , 2004, The Journal of antimicrobial chemotherapy.
[30] V. Yu,et al. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] D. Stevens,et al. A review of linezolid: the first oxazolidinone antibiotic , 2004, Expert review of anti-infective therapy.
[32] M. Brier,et al. Pharmacokinetics of Linezolid in Subjects with Renal Dysfunction , 2003, Antimicrobial Agents and Chemotherapy.
[33] G. French. Safety and tolerability of linezolid. , 2003, The Journal of antimicrobial chemotherapy.
[34] A. MacGowan,et al. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections. , 2003, The Journal of antimicrobial chemotherapy.
[35] Jerome J. Schentag,et al. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia. , 2003, Annals of Oncology.
[36] W. Bernstein,et al. Mechanisms for Linezolid-Induced Anemia and Thrombocytopenia , 2003, The Annals of pharmacotherapy.
[37] Jerome J. Schentag,et al. Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program , 2003, Antimicrobial Agents and Chemotherapy.
[38] S. Gerson,et al. Hematologic Effects of Linezolid: Summary of Clinical Experience , 2002, Antimicrobial Agents and Chemotherapy.
[39] S. Schichman,et al. Linezolid-induced pure red blood cell aplasia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] M. Zervos,et al. Thrombocytopenia associated with linezolid therapy. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] M. G. Johnson,et al. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[42] J. C. Maddox,et al. Linezolid and reversible myelosuppression. , 2001, JAMA.
[43] O. Phillips,et al. Determination of linezolid in human plasma by LC-MS-MS. , 2001, The Analyst.
[44] H. Aoki,et al. The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria , 1998, Antimicrobial Agents and Chemotherapy.
[45] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .